Navigation Links
Winner Medical Reports Third Quarter Fiscal 2009 Results
Date:8/11/2009

SHENZHEN, China, Aug. 11 /PRNewswire-Asia/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG) ("Winner Medical", or the "Company"), today reported unaudited financial results for the third quarter ended June 30, 2009. The Company's results are detailed in its form 10-Q, filed today with the United States Securities and Exchange Commission.

    Third Quarter 2009 Highlights
    -- Total net sales revenue increased by 5.56% over the third quarter of
       fiscal 2008 to $24.36 million
    -- Gross profit increased by 20.12% over the third quarter of fiscal 2008
       to $7.18 million
    -- Operating income increased by 72.93% over the third quarter of fiscal
       2008 to $3.72 million
    -- Net income increased by 76.40% over the third quarter of fiscal 2008 to
       $3.06 million
    -- Net income per share for the third quarter of 2009 was $0.07 per basic
       and diluted share, compared to $0.03 per basic and diluted share for
       the third quarter of fiscal 2008

Jianquan Li, Chairman and Chief Executive Officer of Winner Medical, commented, "During the third quarter, we experienced a robust growth in profits while maintaining a solid increase in revenue. The huge improvement in gross margin and net margin is the result of our implementation of cost control measures, such as lean production and equipment technical improvements which optimize production efficiency and reduce unit production cost."

Mr. Li continued, "Another factor that drives the increase in our overall gross and net profit margin is that the PurCotton products reached the break-even point and started making profit during the month of June. The recognition of top-tier clients of the premium quality of our PurCotton products led to the increased sales volume. We are confident that this new product will be the growth driver over the mid- to long-term."

Third Quarter 2009 Unaudited Financial Results

Revenue: Winner Medical reported net sales revenue of $24.36 million, a 5.56% increase over the third quarter of fiscal 2008. Healthy revenue growth was mainly due to strong demand from China as a result of the medical reform in China, and the Company's effort to develop the China market; and the increased sales of PurCotton products to China, the United States, Europe and Japan.

Gross Profit: For the third quarter of fiscal 2009, gross profit was $7.18 million, an increase of 20.12% over $5.98 million in the same period of fiscal 2008. Gross margin was 29.49%, versus 25.91% achieved in the third quarter of fiscal 2008. The increase in gross margin was mainly due to improvement of the Company's cost control, equipment technical improvement and lean production management that increased production efficiency and reduced production waste; the tax rebate rate for exports from China increased by two percent; and the PurCotton products started making profit during the month of June 2009 compared to losses from these products during the same period last year.

Operating Expenses: Selling, general and administrative expenses decreased by 1.53% to $3.60 million in the third quarter of fiscal 2009, from $3.66 million in the third quarter of fiscal 2008. During this quarter, the decrease in operating expenses was mainly due to the decreased transportation expense for export sales compared with the same period last year as a result of the decline of unit transportation fee.

Operating Income: During the period, operating income was $3.72 million, an increase of 72.93% compared with $2.15 million in the same quarter of 2008. The increase was mainly attributed to decreased export transportation fees, and improved production management to reduce manufacture cost.

Income Taxes: The income tax provision for the third quarter of fiscal 2009 was $695,000, up from -$271,000 for the same period in fiscal 2008. The increase in tax provision was mainly due to a change in tax rate for the Company's subsidiaries in China as a result of the Chinese income tax reform that came into effect on January 1, 2008, and the cancellation of tax return policy for purchasing domestic machinery.

Net income: Net income increased by 76.40% to $3.06 million, or $0.07 per basic and diluted share, compared to net income of $1.74 million, or $0.04 per basic and diluted share, for the third quarter of the last fiscal year. This increase can be attributed to improved production management to reduce manufacture unit cost and improve production efficiency, relatively stable RMB against foreign currency exchange rate, and the decrease in transportation expenses.

Nine Months Ended June 30, 2009 Unaudited Financial Results

Revenue: Winner Medical reported net sales revenue of $70.72 million, a 17.30% increase over the nine months ended June 30, 2009. Healthy revenue growth was mainly due to strong demand, particularly in North and South America and China; the net sales to North and South American customers was $13.55 million for the nine months ended June 30, 2009, an increase of 61.06% compared to the same period last year. The net sales to Chinese customers were $11.5 million for the nine months ended June 30, 2009, an increase of 32.49%, compared to the same period last year.

Gross Profit: For the nine months ended June 30, 2009, gross profit was $19.59 million, an increase of 32.96% over $14.73 million in the same period of fiscal 2008. Gross margin was 27.70%, versus 24.43% achieved in the nine months ended June 30, 2008. The increase in gross margin was mainly due to improvement of the Company's cost control, equipment technical improvement and lean production management that increased production efficiency and reduced production waste; the tax rebate rate for exports from China increased by two percent; and the PurCotton products started making profit during the month of June 2009, compared to losses from these products during the same period last year.

Operating Expenses: Selling, general and administrative expenses increased by 12.69% to $11.92 million during the nine months ended June 30, 2009, from $10.58 million during the nine months ended June 30, 2008. The increase in operating expenses was mainly due to the increase in research and development expenses, increase in salary and welfare for the management and administrative staff, and increase in related administrative expenses, such as depreciation and amortization for Winner Medical (Huanggang) Co., Ltd.

Operating Income: During the period, operating income was $7.57 million, an increase of 95% compared with $3.88 million of the same period of 2008. The increase was mainly attributed to decreased export transportation fees, and improved production management to reduce manufacture cost.

Income Taxes: The income tax provision for the nine months ended June 30, 2009 was $1,414,000, up from $113,000 for the same period in fiscal 2008. The increase in tax provision was mainly due to a change in tax rate for the Company's subsidiaries in China as a result of the Chinese Income Tax reform that came into effect on January 1, 2008, and the cancellation of tax return policy for purchasing domestic machinery.

Net income: Net income increased by 78.24% to $6.18 million, or $0.14 per basic and diluted share, compared to net income of $3.47 million, or $0.08 per basic and diluted share, for the same period of the last fiscal year. This increase can be attributed to improved production management to reduce manufacture unit cost and improve production efficiency, relatively stable RMB against foreign currency exchange rate, and the decrease in transportation expenses.

Balance Sheet

Cash and cash equivalents as of June 30, 2009 was approximately $7.84 million, compared with $6.46 million as of September 30, 2008. The Company's working capital as of June 30, 2009 was $20.78 million compared with $12.37 million as of September 30, 2008. Net operating cash flow during the nine months ended June 30, 2008 was $9.94 million, an increase of $6.07 million compared with the same period in fiscal 2008.

Third Quarter 2009 Operational Highlights

Medical care, Wound care and Home care products in China

Winner Medical develops China market through distributors, drugstore chains, and hospitals. As a result, sales revenue from China was $5.02 million for the three months ended June 30, 2009, against $3.34 million in the same period last year, an increase of 50.57%. As a percentage of net revenues, the sales revenue from China increased 20.62% for the three months ended June 30, 2009 from 14.46% for the three months ended June 30, 2008.

PurCotton:

In the third quarter of fiscal 2009, the Company's PurCotton sales grew steadily. The Company has $1,207,000 in raw material sales in the third quarter of fiscal 2009, compared with $1,108,000 sales during the last quarter. Net loss from PurCotton products during three month ended June 30, 2009 was approximately $5,000, as compared with a net loss of $487,000 in the same period last year. The PurCotton sales were mainly to customers in China, Japan, and the United States. At the same time, the Company is in the stage of processing trial orders of PurCotton finished medical products, such as operation room towels and sponges, with customers in North America and Europe.

Winner Medical believes that revenue from PurCotton will grow rapidly in the future. In July 2009, Winner Medical signed an agreement with a leading consumer products company in China to provide PurCotton rolls, which will be processed into feminine products and then distributed throughout China by the consumer products company. Including this deal, Winner Medical's PurCotton sales to customers in China, Japan, the United States, and other countries are expected to reach approximately $700,000 per month or approximately 150 tonnes per month. As a result of the continuous sales expansion, the sale of PurCotton products reached the break-even point, and started to make a profit during the month of June 2009.

2009 Guidance

The Company maintains its estimate that revenue in fiscal year 2009 will range from $98.33 million to $100.90 million, an increase of 15% to 18% compared to fiscal year of 2008.

Conference Call

Winner Medical's senior management will host a conference call at 5am (Pacific)/ 8am (Eastern)/ 8pm (Shenzhen/ Hong Kong) on Wednesday, August 12, 2009 to discuss its 2008/09 third quarter results and recent business developments. The conference call can be accessed by calling 866-510-0705 (US), 10-800-130-0399 (South China), 10-800-152-1490 (North China), or 800-96-3844 (HK); Passcode: 24788174. A telephone replay will be available shortly after the conclusion of the call and will be accessible through August 19, 2009 by calling 888-286-8010 (US) or +1-617-801-6888 (International); Passcode: 19154413.

About Winner Medical

Winner Medical is a leading manufacturer in the medical dressing industry (medical and wound care products) in China. Headquartered in Shenzhen, the Company has seven wholly owned manufacturing and distribution facilities, four joint-venture factories and over 5,000 employees. The Company engages in the manufacture, sale, research, and development of medical care products, wound care products, home care products and PurCotton products, a nonwoven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the United States and Japan serving as the top three markets. The Company currently holds 50 patents and patent applications for various products and manufacturing processes and is one of the few Chinese companies licensed by the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the United States market. To learn more about Winner Medical, visit Winner Medical's web site http://www.winnermedical.com .

Forward-Looking Statements

This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward-looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

   For more information, please contact:

    Investor Relations Contacts:
     Peng Zhai
     Assistant Manager, Investor Relations
     Winner Medical Group Inc.
     Tel:   +86-755-2806-6858
     Email: peng.zhai@winnermedical.com



    Winner Medical Group Inc.
    Consolidated Statements of Income and Comprehensive Income

                                Three months ended        Nine months ended
                                      June 30                  June 30
                                2009         2008         2009        2008
                             (Unaudited)  (Unaudited)  (Unaudited) (Unaudited)
                                 US$          US$          US$         US$

    Net sales                24,357,878   23,073,575   70,715,298   60,287,476

    Cost of sales           (17,176,129) (17,094,433) (51,128,269) (45,556,952)
    Gross profit              7,181,749    5,979,142   19,587,029   14,730,524

    Other operating (loss)
     income, net                 96,183      (77,968)     987,432      359,587
    Exchange difference, net     47,432      (90,993)  (1,082,265)    (627,877)
    Selling, general and
     administrative expenses (3,600,442)  (3,655,928) (11,923,716) (10,581,098)

    Income from operations    3,724,922    2,154,253    7,568,480    3,881,136
    Interest income              19,069       13,591       42,888       32,328
    Interest expense            (70,884)    (196,275)    (397,940)    (435,140)
    Equity in earnings of
     50 percent or less          86,446       15,766      309,584       39,731
     owned persons
    Income before income
     taxes and minority
     interests                3,759,553    1,987,335    7,523,012    3,518,055

    Income taxes               (694,718)    (271,384)  (1,414,383)    (112,801)
    Income before minority
     interests                3,064,835    1,715,951    6,108,629    3,405,254

    Minority interests           (1,183)      20,902       74,196       63,903
    Net income                3,063,652    1,736,853    6,182,825    3,469,157

    Other comprehensive
     income
      Foreign currency
       translation               37,243    1,433,644      (87,899)   5,773,517
       difference

    Comprehensive income      3,100,895    3,170,497    6,094,926    9,242,674


    Net income per share
    - basic                        0.07         0.04         0.14         0.08
    - diluted                      0.07         0.04         0.14         0.08

    Weighted average common
     stock
    outstanding
    - basic                  44,727,171   44,727,171   44,727,171   44,727,171
    - diluted                44,908,262   44,849,292   44,962,549   44,849,292



    Winner Medical Group Inc.
    Consolidated Balance Sheets

                                                       June 30   September 30
                                                        2009         2008
                                                     (Unaudited)  (Unaudited)
                                                         US$          US$
                                    ASSETS
    Current assets:
      Cash and cash equivalents                       7,837,701    6,462,505
      Restricted bank deposits                           99,694      126,749
      Accounts receivable, less allowances for
       doubtful accounts of US$114,596 and
       US$100,964 at June 30, 2009 and
       September 30, 2008, respectively              11,502,982   13,516,688
      Amounts due from affiliated companies             365,781      349,359
      Inventories                                    14,785,842   15,839,587
      Prepaid expenses and other receivable           5,279,048    4,734,503
      Income taxes recoverable                           30,897       99,126
      Deferred tax assets                               223,726      207,798
          Total current assets                       40,125,671   41,336,315
      Property, plant and equipment, net             55,943,053   57,937,881
      Held-for-sale asset                                    --      607,423
      Investment in equity investees                  1,845,291    1,518,848
      Intangible assets, net                            153,404      126,141
      Non-current restricted bank deposits              158,193           --
      Prepaid expenses and other receivable             117,170      233,203
      Deferred tax assets                               281,222      158,280
          Total assets                               98,624,004  101,918,091

                      LIABILITIES AND STOCKHOLDERS' EQUITY

    Current liabilities:
      Short-term bank loans                           7,757,725   15,033,073
      Accounts payable                                6,090,115    8,271,926
      Accrued payroll and employee benefits           1,790,164    1,891,410
      Customer deposits                                 476,064      458,303
      Other accrued liabilities                       2,057,541    2,518,326
      Amounts due to affiliated companies                56,384      136,481
      Income taxes payable                            1,118,719      656,550
          Total current liabilities                  19,346,712   28,966,069
    Deferred tax liabilities                             41,881       41,965
          Total liabilities                          19,388,593   29,008,034

    Commitments and contingencies

    Minority interests                                   74,111      148,306

    Stockholders' equity:
      Common stock, par value $0.001 per share;
       authorized 495,000,000, issued and
       outstanding June 30, 2009 - 44,727,171
       shares; September 30, 2008 - 44,727,171
       shares                                            44,727       44,727
    Additional paid-in capital                       31,147,950   30,843,327
    Retained earnings                                33,851,423   28,791,259
    Statutory reserves                                3,428,095    2,305,434
    Accumulated other comprehensive income           10,689,105   10,777,004
          Total stockholders' equity                 79,161,300   72,761,751
          Total liabilities and
           stockholders' equity                      98,624,004  101,918,091


'/>"/>
SOURCE Winner Medical Group Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Good Clinical Practice Journal Awards: Winners Announced
2. ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library
3. Medifast Announces Winners of Mother-Daughter Challenge
4. SAMHSA Announces First Science and Service Award Winners
5. Vida Health Communications, Inc. to Be Honored as Tibbetts Award Winner
6. No Clear Winner in Diabetes Treatment Trial
7. National Battle of the Hospital Chefs Cooks Up a Winner
8. National Cherokee Inspired Comfort Award Winners Announced
9. Bottomless bowls are an Ig Nobel winner
10. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
11. CaliforniaVolunteers Announces Winners of Find It. Do It. Share It. Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... ... and pharmaceutical organizations to build intelligent, connected applications, was named the best Sales ... , The winner announcement was made today by the Software & Information ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 ... the National Family Partnership and the Drug Enforcement Administration as part of the National ... the 10 winning schools who decorated their campuses with this year’s Red Ribbon Week ...
(Date:11/30/2016)... Northridge, CA (PRWEB) , ... November 30, 2016 ... ... Elyson, announce that they now offer a comprehensive in-house dental plan for all ... dentists have developed a plan that gives patients a number of perks, including ...
(Date:11/30/2016)... PALMYRA, Wisconsin (PRWEB) , ... November 30, 2016 ... ... inclusion in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of ... consecutive year on the list, having ranked from 2008-2016. In addition, Standard Process ...
(Date:11/30/2016)... Chino Hills, CA (PRWEB) , ... November 30, ... ... in eating disorder and mental health treatment has announced the opening of a ... specialized residential treatment for girls with mental health issues such as severe anxiety, ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... FRANCISCO , Dec. 2, 2016  PipelineRx, a ... telepharmacy, will be offering demonstrations of its SaaS-based ... Society of Health-System Pharmacists 2016 Midyear Clinical Meeting ... Vegas . With nearly 300 hospital clients ... services and technology designed to dramatically improve pharmacy ...
(Date:12/2/2016)... December 2, 2016 On Thursday, ... honored excellence in research, development and innovation in the ... dinner was held in the presence of Sergey Tsyb, ... Russian Federation , Natalia Sanina, First Vice ... Murashko , Head of Roszdravnadzor, National Service of Control ...
(Date:12/2/2016)...  Eli Lilly and Company (NYSE: LLY ... provide updated financial guidance for 2016 on Thursday, December ... on that day with the investment community and media ... The conference call will begin at 10 a.m. ET. ... live webcast of the conference call through a link ...
Breaking Medicine Technology: